Renal cell carcinoma (RCC) is most commonly diagnosed as an incidental finding on cross-
sectional imaging and represents a significant clinical challenge. Although most patients
have a surgically curable lesion at the time of diagnosis, the variability in the biologic
behavior of the different histologic subtypes and tumor grade of RCC, together with the
increasing array of management options, creates uncertainty for the optimal clinical
approach to individual patients. State-of-the-art magnetic resonance imaging (MRI) provides …